At the time of exit to Zoetis, Pharmaq was a market leader in aquatic vaccines for farmed fish.

The company also provided fish therapeutics and diagnostics services to its customers and was focused on being the innovation leader in its core markets in Norway, Chile and the UK but also in emerging markets in Asia.